Sun pharmaceutical News: Sun pharmaceutical Latest News, Sun pharmaceutical Today news, Sun pharmaceutical Breaking News

Divis Labs GLP drug manufacturing opportunity

Nuvama’s top 5 pharma sector ‘Buy’ with up to 43% upside potential

Brokerage major Nuvama turns bullish on five pharma and healthcare stocks, citing semaglutide launches, CGHS rate revisions, capacity expansion and…

Updated: February 11, 2026 16:24 IST

stocks making biggest moves midday Sensex Nifty

Stocks making biggest moves midday: IndiGo, Eternal, Tanla, United Spirits, Ujjivan Small Finance Bank and more

Markets stay volatile as select midcaps like Tanla Platforms and Bandhan Bank surge even as IndiGo and Eternal slip post-Q3…

Updated: January 23, 2026 15:08 IST

Sun Pharma Lupin Torrent Intas GLP-1 obesity drugs India 2026

Rs 10,000-crore opportunity: Sun Pharma, Lupin, Torrent to lead 2026 weight-loss market as Ozempic patent expires

A revolution in India’s weight-loss market is coming. As Semaglutide’s patent ends in 2026, Sun Pharma, Lupin, Torrent, and Intas…

December 31, 2025 17:06 IST

Sun Pharma recalls 17,000 units of antifungal shampoo in US over manufacturing issues

Sun Pharma-owned Taro Pharmaceutical is recalling over 17,000 units of antifungal Ciclopirox Shampoo in the US due to manufacturing-related quality…

December 25, 2025 17:05 IST

Sun Pharmaceutical share price today, Sun Pharma, Sun Pharma stock, Sun Pharma share price

Sun Pharma in spotlight: Buy or Hold? 2 brokerages, 2 targets – Here’s what it means for investors

Sun Pharma receives a ‘Buy’ from Jefferies and ‘Hold’ from Nuvama; review both targets to decide your next move on…

September 25, 2025 10:50 IST

Sun Pharma launches LEQSELVI in US for severe hair loss

Sun Pharma launches key alopecia drug in US, experts estimate $200–300 million market potential

Updated: July 15, 2025 14:30 IST

Sun Pharma, pharma industry, Dilip Shanghvi, USFDA, manufacturing, compliance issues, US FDA inspection, R&D spend, revenue, specialty revenue

Sun Pharma steps up USFDA compliance drive: What’s changing at Halol, Mohali and Dadra?

Sun Pharma is stepping up regulatory compliance efforts at three USFDA-flagged facilities, including Halol, Mohali, and Dadra.

July 8, 2025 11:07 IST

3 ‘Buy’ recommendation by Nomura, with up to 28% upside

Nomura issues ‘Buy’ calls on IndusInd Bank, Voltas, and Sun Pharma with up to 28% upside—read the full analysis to…

June 20, 2025 17:06 IST

Is the Halol hurdle too high for Sun Pharma? 4 reasons why Nomura sees limited upside potential

Sun Pharma’s Halol issues limit potential; Nomura sees a 17% upside. Stay updated on regulatory developments at Halol facility.

June 17, 2025 12:34 IST

stocks to watch today, Indian stock market news, Q1 FY26 corporate earnings

From SpiceJet, Adani Ports, Adani Green Energy to Hindustan Zinc – Here are 8 stocks to watch

Stocks to watch today, June 16: GIFT Nifty indicates a flat start for domestic indices. Here are top stocks to…

June 16, 2025 06:40 IST

Sun Pharma shares fall over 4% today. Here’s what’s behind the drop

Sun Pharmaceuticals share price today, May 23: Sun Pharma shares drop 4.77%, hit by weak earnings; explore future market moves!

May 23, 2025 13:38 IST

Gland Pharma share price, Gland Pharma Motilal Oswal report

Why are pharma stocks falling despite 2,200-point Sensex rally? Nifty Pharma slides 2%

Nifty Pharma share price today, May 12: Pharma stocks fall as Trump plans to slash US drug prices. Discover more…

May 12, 2025 10:49 IST

From TCS, Infosys, Bharti Hexacom to Tata Steel – Here are 8 stocks to watch

Stocks to watch today, April 11: GIFT Nifty was trading up 2.07% to 22,953, which indicates a positive start for…

April 11, 2025 07:13 IST

Motilal Oswal’s top 3 Buy recommendations at this hour

Explore Motilal Oswal’s top stock picks: Sun Pharma, Sapphire Foods, and Bharti Hexacom. Discover growth potential and target prices now!

March 11, 2025 16:37 IST

Sun Pharma share price today, Sun Pharma share news today

Sun Pharma shares slip over 3% after US court’s ruling on LEQSELVI launch

Sun Pharmaceutical shares have delivered impressive gains across multiple time frames, reflecting strong investor interest. Over the past three months,…

Updated: November 4, 2024 11:18 IST

Dilip Sanghvi, Dilip Sanghvi net worth, Dilip Sanghvi lifestyle, Dilip Sanghvi forbes, who is Dilip Sanghvi, Sun Pharma, Dilip Sanghvi Sun Pharma, lifestyle

Who is Indian billionaire Dilip Sanghvi, the man behind Sun Pharma? Know about his Rs 15.65 lakh crore net worth

Founder of Sun Pharma, Shanghvi commands a business empire generating $5.4 billion (approximately Rs 44,971 crore) in revenue.

Updated: December 21, 2023 00:37 IST

Sun Pharma, Bayer, Bayer pharma, cardiac care, heart patients, healthcare news, pharma news,

Sun Pharma Q2 Results: Profit rises 5% to Rs 2375.51 crore, beats estimates

Sun Pharma posted revenue from operations at Rs 12,192.41 crore, up 11.3 per cent as against Rs 10,952.28 crore during…

November 1, 2023 15:49 IST

Sun Pharma, Eye diseases, Eye disorder, dry eyes, trial results, healthcare news, pharma news,

Sun Pharma and Pharmazz Inc. enter into licensing agreement for introducing ischemic stroke drug in India

As per agreement terms, Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide).

September 14, 2023 13:30 IST

Sun Pharmaceutical

Related News

Trending Topics